FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to clinical Immunology and Infectious diseases, and may be used for treating chronic refractory herpes virus infection. That is ensured by using autologous IFN-alpha induced dendritic cells loaded with recombinant herpes virus antigen and administered to the patient subcutaneously by two courses in a combination with a preparation of recombinant interleukin-2 as an adjuvant.
EFFECT: method enables reducing a number of recurrences and a severity of clinical manifestations of herpes virus infection ensured by induction of the effective antigen-specific cell-mediated response and maintaining it at an adequate level for a long period of time.
1 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR IMMUNE THERAPY OF CHRONIC VIRAL HEPATITIS C | 2016 |
|
RU2637631C2 |
| METHOD OF IMMUNOTHERAPY MALIGNANT TUMORS OF BRAIN | 2018 |
|
RU2686756C1 |
| METHOD OF TREATMENT OF PATIENTS WITH HERPES VIRUS INFECTION USING IN VITRO ACTIVATED AUTOLOGICAL LYMPHOCYTES | 2022 |
|
RU2799141C2 |
| METHOD OF GENERATION OF ANTIGEN-SPECIFIC CYTOTOXIC CELLS ACTIVE AGAINST HEPATITIS B INFECTED CELLS | 2008 |
|
RU2366707C1 |
| METHOD FOR TREATING THE CASES OF CHRONIC DIFFUSE HEPATIC DISEASES | 2004 |
|
RU2283113C2 |
| METHOD FOR GENERATION OF SPECIFIC IMMUNE RESPONSE ON HUMAN IMMUNODEFICIENCY VIRUS ANTIGENS | 2011 |
|
RU2465324C1 |
| METHOD FOR IMMUNOTHERAPY OF CEREBRAL MALIGNANT TUMORS | 2004 |
|
RU2262941C2 |
| IMMUNOTHERAPY OF BREAST CANCER USING ANTIGEN-ACTIVATED DENDRITIC CELLS | 2016 |
|
RU2645464C1 |
| METHOD FOR PREPARING AUTOLOGOUS TUBERCULOSIS VACCINE | 2008 |
|
RU2372936C1 |
| METHOD OF LOADING DENDRITIC CELLS WITH ANTIGEN OF INFECTIOUS ORIGIN Opistorchis felineus | 2011 |
|
RU2486238C1 |
